Industry Verticals »

All Categories

Insights »

About TMR »

Cardiac Biomarker Diagnostic Kits Market

Cardiac Biomarker Diagnostic Kits Market (Product - Troponin Test Kits, CK-MB Test Kits, Myoglobin Test Kits, BNP Test Kit, C-reactive Protein (hsCRP), Other Biomarkers; Disease Indication - Angina Pectoris, Myocardial Infraction (MI), Cardiac Heart Failure; Testing - Laboratory Testing, Point of Care Testing; End user - Hospitals, Clinics, Diagnostics Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the Global Cardiac Biomarker Diagnostic Kits market for the historical period 2017–2018 and forecast period 2019–2027, rising prevalence of cardiovascular disorders across the globe and advancements in novel technologies are projected to drive the global cardiac biomarker diagnostic kits market during the forecast period
  • According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2.2 Bn in 2018 and is anticipated to grow at a CAGR of 5.2% from 2019 to 2027

Rising prevalence of cardiovascular diseases across the globe : Key Driver

  • Growing prevalence of cardiovascular disorders across the globe is a key factor driving the global cardiac biomarker diagnostic kits market.
  • For instance, as per World Health Organization (WHO), every year around 17.9 million people die due to cardiovascular diseases globally which constitutes an estimated 31% of all deaths worldwide.
  • Advancements and technological innovations prompt patients to opt for easy-to-use and portable medical devices, which is also fuelling the growth of global cardiac biomarker diagnostic kits market
  • Moreover, rising government funding for cardiovascular disease treatment, early detection to track the heart condition, and integration of cardiology & IT are also some of the major factors responsible for the growth of global cardiac biomarker diagnostic kits market

Lack of trained staff and appropriate health care infrastructure in developing economies hamper the market growth

  • A cardiac biomarker involves various technical skills, which require appropriate training to handle the device. Sometimes, hospitals or people from developing countries lack awareness about the biomarker and its handling. It creates a barrier between the manufacturing of the device and usage, thereby restraining the market
  • Also Lack of awareness in developing countries and Negative impact of economic constraint in certain regions & pricing pressure can restrain the global market  growth

Global Cardiac Biomarker Diagnostic Kits Market: North America dominated the global market

  • On the basis of region, the cardiac biomarker diagnostic kits market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
  • North America region is accounted for major market share in the global market owing to higher patient population for cardiac diseases, expansion of high-sensitive cardiac biomarkers, rise in acceptance of point-of-care instruments by hospitals and clinics, advancements in technology, and development of high sensitivity POC testing in the region
  • However, Asia-Pacific region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly attributed to developing health care infrastructure, large patient population, increase in funding and investment toward the development of cardiac analyzers, and surge in focus of both international and domestic players in the region

Global Cardiac Biomarker Diagnostic Kits Market: Competitive Landscape

  • This report profiles major players in the global cardiac biomarker diagnostic kits market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global cardiac biomarker diagnostic kits market is highly consolidated, with a few global players accounting for a major share in market.
  • Leading players operating in the global Cardiac biomarker diagnostic kits market are
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Siemens Healthineers
    • bioMérieux SA
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • among others

Global Cardiac Biomarker Diagnostic Kits Market: Key Developments

Key players in the global cardiac biomarker diagnostic kits market are engaged in regulatory approvals, new product development, technological advancements, merger, acquisitions & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global cardiac biomarker diagnostic kits market. A few expansion strategies adopted by players operating in the global Cardiac biomarker diagnostic kits market are:

  • In April 2019, US FDA has approved Ortho Clinical Diagnostics VITROS XT MicroSlides which features new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide
  • In September 2018, Abbott receives CE Mark for first troponin test to help predict the chance of heart attack in apparently healthy adults potentially months to years in advance.

 The report on the global cardiac biomarker diagnostic kits market discussed individual strategies, followed by company profiles of manufacturers of cardiac biomarker diagnostic kits. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiac biomarker diagnostic kits market

Frequently Asked Questions

What is the total market worth of cardiac biomarker diagnostic kits market?

Cardiac biomarker diagnostic kits market to reach valuation of around US$ 3.5 Bn by 2027

What is the anticipated CAGR of the cardiac biomarker diagnostic kits market in the forecast period?

Cardiac biomarker diagnostic kits market is anticipated to grow at a CAGR of 5.2% from 2019 to 2027

What are the key driving factors for the growth of the cardiac biomarker diagnostic kits market?

Cardiac biomarker diagnostic kits market is driven by rising prevalence of cardiovascular disorders across the globe

Which region is expected to project the highest market share in the global cardiac biomarker diagnostic kits market?

North America accounted for a major share of the global cardiac biomarker diagnostic kits market owing to higher patient population for cardiac diseases

Who are the key players in the cardiac biomarker diagnostic kits market?

Key players in the global Cardiac biomarker diagnostic kits market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers, bioMérieux SA, Ortho Clinical Diagnostics

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cardiac Biomarker Diagnostic Kits Market

4. Market Overview

    4.1. Introduction

        4.1.1. Products Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

            4.3.1.1. Rising prevalence of cardiovascular disorders

            4.3.1.2. Advancements in novel technologies

            4.3.1.3. Integration of cardiology & IT

            4.3.1.4. Early detection to track the heart condition

            4.3.1.5. Government funding for cardiovascular disease treatment

        4.3.2. Restraints

            4.3.2.1. Negative impact of economic constraint in certain regions & pricing pressure

            4.3.2.2. Lack of trained staff and appropriate health care infrastructure in developing economies

            4.3.2.3. Lack of awareness in developing countries

            4.3.2.4. Regulatory challenges

        4.3.3. Trends

    4.4. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Regulatory Scenario by Region/Globally

    5.2. Key Mergers & Acquisitions

    5.3. Reimbursement Scenario 

    5.4. Cardiac Diseases Prevalence Rate Globally with Key Countries

    5.5. Top 3 players operating in the market space

6. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Products 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

        6.3.1. Troponin Test Kits 

        6.3.2. CK-MB Test Kits

        6.3.3. Myoglobin Test Kits

        6.3.4. BNP Test Kit

        6.3.5. C-reactive Protein (hsCRP)

        6.3.6. Others

    6.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Products 

7. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Testing 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

        7.3.1. Laboratory Testing

        7.3.2. Pont-of-care Testing

    7.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Testing 

8. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Application 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

        8.3.1. Angina Pectoris

        8.3.2. Myocardial Infraction

        8.3.3. Cardiac Heart Failure

        8.3.4. Other

    8.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application 

9. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by End-user 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

        9.3.1. Hospitals

        9.3.2. Clinics

        9.3.3. Diagnostic Laboratory

        9.3.4. Others

    9.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by End-user 

10. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Region

        10.2.1. North America 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Latin America 

        10.2.5. Middle East & Africa 

    10.3. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Region

11. North America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

     11.1. Introduction

        11.1.1. Key Findings

    11.2. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

        11.2.1. Troponin Test Kits 

        11.2.2. CK-MB Test Kits

        11.2.3. Myoglobin Test Kits

        11.2.4. BNP Test Kit

        11.2.5. C-reactive Protein (hsCRP)

        11.2.6. Others

    11.3. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

        11.3.1. Laboratory Testing

        11.3.2. Pont-of-care Testing

    11.4. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

        11.4.1. Angina Pectoris

        11.4.2. Myocardial Infraction

        11.4.3. Cardiac Heart Failure

        11.4.4. Other

    11.5. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

        11.5.1. Hospitals

        11.5.2. Clinics

        11.5.3. Diagnostic Laboratory

        11.5.4. Others

    11.6. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

        11.7.1. By Products 

        11.7.2. By Testing 

        11.7.3. By Application 

        11.7.4. By End-user 

        11.7.5. By Country

12. Europe Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

        12.2.1. Troponin Test Kits 

        12.2.2. CK-MB Test Kits

        12.2.3. Myoglobin Test Kits

        12.2.4. BNP Test Kit

        12.2.5. C-reactive Protein (hsCRP)

        12.2.6. Others

    12.3. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

        12.3.1. Laboratory Testing

        12.3.2. Pont-of-care Testing

    12.4. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

        12.4.1. Angina Pectoris

        12.4.2. Myocardial Infraction

        12.4.3. Cardiac Heart Failure

        12.4.4. Other

    12.5. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

        12.5.1. Hospitals

        12.5.2. Clinics

        12.5.3. Diagnostic Laboratory

        12.5.4. Others

    12.6. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

        12.7.1. By Products 

        12.7.2. By Testing 

        12.7.3. by Application 

        12.7.4. by End-user 

        12.7.5. by Country/Sub-region

13. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

        13.2.1. Troponin Test Kits 

        13.2.2. CK-MB Test Kits

        13.2.3. Myoglobin Test Kits

        13.2.4. BNP Test Kit

        13.2.5. C-reactive Protein (hsCRP)

        13.2.6. Others

    13.3. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

        13.3.1. Laboratory Testing

        13.3.2. Pont-of-care Testing

    13.4. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

        13.4.1. Angina Pectoris

        13.4.2. Myocardial Infraction

        13.4.3. Cardiac Heart Failure

        13.4.4. Other

    13.5. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

        13.5.1. Hospitals

        13.5.2. Clinics

        13.5.3. Diagnostic Laboratory

        13.5.4. Others

    13.6. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

        13.7.1. By Products 

        13.7.2. By Testing 

        13.7.3. By Application 

        13.7.4. By End-user 

        13.7.5. By Country/Sub-region

14. Latin America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

        14.2.1. Troponin Test Kits 

        14.2.2. CK-MB Test Kits

        14.2.3. Myoglobin Test Kits

        14.2.4. BNP Test Kit

        14.2.5. C-reactive Protein (hsCRP)

        14.2.6. Others

    14.3. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

        14.3.1. Laboratory Testing

        14.3.2. Pont-of-care Testing

    14.4. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

        14.4.1. Angina Pectoris

        14.4.2. Myocardial Infraction

        14.4.3. Cardiac Heart Failure

        14.4.4. Other

    14.5. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

        14.5.1. Hospitals

        14.5.2. Clinics

        14.5.3. Diagnostic Laboratory

        14.5.4. Others

    14.6. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

        14.7.1. By Products 

        14.7.2. By Testing 

        14.7.3. By Application 

        14.7.4. By End-user 

        14.7.5. By Country/Sub-region

15. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

        15.2.1. Troponin Test Kits 

        15.2.2. CK-MB Test Kits

        15.2.3. Myoglobin Test Kits

        15.2.4. BNP Test Kit

        15.2.5. C-reactive Protein (hsCRP)

        15.2.6. Others

    15.3. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

        15.3.1. Laboratory Testing

        15.3.2. Pont-of-care Testing

    15.4. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

        15.4.1. Angina Pectoris

        15.4.2. Myocardial Infraction

        15.4.3. Cardiac Heart Failure

        15.4.4. Other

    15.5. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

        15.5.1. Hospitals

        15.5.2. Clinics

        15.5.3. Diagnostic Laboratory

        15.5.4. Others

    15.6. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

        15.7.1. By Products 

        15.7.2. By Testing 

        15.7.3. By Application 

        15.7.4. By End-user 

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by Tier and Size of companies)

    16.2. Market Share Analysis by Company (2017)

    16.3. Competitive Business Strategies

    16.4. Company Profiles

        16.4.1. Abbott Laboratories

            16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.1.2. Company Financials

            16.4.1.3. Growth Strategies

            16.4.1.4. SWOT Analysis

        16.4.2. Hoffmann-La Roche AG

            16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.2.2. Company Financials

            16.4.2.3. Growth Strategies

            16.4.2.4. SWOT Analysis

        16.4.3. Bio-Rad Laboratories

            16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.3.2. Company Financials

            16.4.3.3. Growth Strategies

            16.4.3.4. SWOT Analysis

        16.4.4. Danaher Corporation

            16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.4.2. Company Financials

            16.4.4.3. Growth Strategies

            16.4.4.4. SWOT Analysis

        16.4.5. Seimens Healthineers

            16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.5.2. Company Financials

            16.4.5.3. Growth Strategies

            16.4.5.4. SWOT Analysis

        16.4.6. Thermofisher Scientific

            16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.6.2. Company Financials

            16.4.6.3. Growth Strategies

            16.4.6.4. SWOT Analysis

        16.4.7. bioMérieux SA

            16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.7.2. Company Financials

            16.4.7.3. Growth Strategies

            16.4.7.4. SWOT Analysis

        16.4.8. Ortho Clinical Diagnostics 

            16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.4.8.2. Company Financials

            16.4.8.3. Growth Strategies

            16.4.8.4. SWOT Analysis

List of Table

Table 01: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

Table 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 07: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 08: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

Table 09: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 10: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 11: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 12: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 13: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

Table 14: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 17: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 18: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

Table 19: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 20: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 22: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 23: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

Table 24: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 25: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 27: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 28: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

Table 29: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 30: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figure

Figure 01: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

Figure 02: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

Figure 03: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Troponin Test Kits, 2017–2027

Figure 04: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CK-MB Test Kits, 2017–2027

Figure 05: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Myoglobin Test Kits, 2017–2027

Figure 06: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by BNP Test Kit, 2017–2027

Figure 07: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by C-reactive Protein (hsCRP), 2017–2027

Figure 08: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Biomarkers, 2017–2027

Figure 09: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

Figure 10: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

Figure 11: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Angina pectoris, 2017–2027

Figure 12: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Myocardial Infraction (MI), 2017–2027

Figure 13: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cardiac Heart Failure, 2017–2027

Figure 14: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 16: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Laboratory Testing, 2017–2027

Figure 17: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Pont-of-care testing, 2017–2027

Figure 18: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

Figure 19: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

Figure 20: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2027

Figure 21: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2017–2027

Figure 22: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratory, 2017–2027

Figure 23: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

Figure 24: Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Region, 2018 and 2027

Figure 25: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis by Region, 2019–2027

Figure 26: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 27: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

Figure 28: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

Figure 29: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

Figure 30: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

Figure 31: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

Figure 32: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

Figure 33: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

Figure 34: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

Figure 35: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2019–2027

Figure 36: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2018 and 2027

Figure 37: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 38: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

Figure 39: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

Figure 40: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

Figure 41: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

Figure 42: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

Figure 43: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

Figure 44: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

Figure 45: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

Figure 46: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 47: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 48: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 49: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

Figure 50: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

Figure 51: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

Figure 52: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

Figure 53: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

Figure 54: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

Figure 55: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

Figure 56: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

Figure 57: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 58: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 59: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 60: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

Figure 61: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

Figure 62: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

Figure 63: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

Figure 64: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

Figure 65: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

Figure 66: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

Figure 67: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

Figure 68: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 69: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 70: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 72: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

Figure 73: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

Figure 74: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

Figure 75: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

Figure 76: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

Figure 77: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

Figure 78: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

Figure 79: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 80: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Cardiac Biomarker Diagnostic Kits Market

Schedule a Call